Search

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

Sanofi and DNDi are co-developing a drug – acoziborole – to treat sleeping sickness.

Environmental sustainability should be a key consideration when selecting solvents for scale-up.

What biosecurity risks do exo-microorganisms pose?

NASA ultimately wants to send humans to Mars – and those humans will need medicines.

Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.

How can we best deliver solubility-challenged small molecules to the clinic?

Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.

What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?